Antitumor activity of noscapine in human non-small cell lung cancer xenograft model

Cancer Chemotherapy and Pharmacology

Volumn 63, Issue 1, 2008, Pages 117-126

  Jackson, Tanise ^a   Chougule, Mahavir B ^a   Ichite, Nkechi ^a   Patlolla, Ram R ^a   Singh, Mandip ^a  

^a FLORIDA A AND M UNIVERSITY   (United States)

Author keywords

Apoptosis; H460; Lung cancer; Noscapine; Xenograft

Indexed keywords

CASPASE 3; DOCETAXEL; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; NOSCAPINE; PROTEIN BAX; PROTEIN BCL 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG MECHANISM; FEMALE; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR VOLUME; XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CARCINOMA, NON-SMALL-CELL LUNG; CASPASE 3; FEMALE; LUNG NEOPLASMS; MICE; MICE, NUDE; NEOPLASM PROTEINS; NOSCAPINE; POLY(ADP-RIBOSE) POLYMERASES; PROTO-ONCOGENE PROTEINS C-BCL-2; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 53149119507     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-008-0720-z     Document Type: Article

References (28)

1. H Wakelee CP Belani 2005 Optimizing first-Line treatment options for patients with advanced NSCLC Oncologist 10 1 10
2. DG Pfister DH Johnson CG Azzoli W Sause TJ Smith S Baker Jr J Olak D Stover JR Strawn AT Turrisi MR Somerfield 2004 American Society of Clinical Oncology Treatment of Unresectable Non-Small-Cell Lung Cancer Guideline: Update 2003 J Clin Oncol 22 2 330 353
3. The International Adjuvant Lung Cancer Trial Collaborative Group 2004 Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small cell lung cancer N Engl J Med 350 351 360
4. T Winton R Livingston D Johnson J Rigas M Johnston C Butts Y Cormier G Goss R Inculet E Vallieres W Fry D Bethune J Ayoub K Ding L Seymour B Graham MS Tsao D Gandara K Kesler T Demmy F Shepherd 2005 Vinorelbine plus cisplatin vs. observation in resected non-small cell lung cancer N Engl J Med 352 2589 2597
5. GM Strauss J Herndon MA Maddaus DW Johnstone EA Johnson DM Watson DJ Sugarbaker RL Schilsky MR Green 2004 Randomized clinical trial of adjuvant chemotherapy with paclitaxel and carboplatin following resection in stage IB non-small cell lung cancer: report of Cancer and Leukemia Group B protocol 9633. J Clin Oncol 22 14S 621s Abstract #7019
6. MA Socinski TE Stinchcombe 2007 Duration of first-line chemotherapy in advanced non-small-cell lung cancer: less is more in the era of effective subsequent therapies J Clin Oncol 25 33 5155 5157
7. MA Jordan 2002 Mechanism of action of antitumor drugs that interact with microtubules and tubulin Curr Med Chem Anticancer Agents 2 1 17
8. S Fleming F Lucas MA Schofield 2001 Therapeutic area review of oncology products and players Expert Opin Emerg Drugs 6 317 329
9. L Van Zuylen J Verweij A Sparreboom 2001 Role of formulation vehicles in taxane pharmacology Invest New Drugs 19 125 141
10. M Markman 2003 Managing taxane toxicities Support Care Cancer 11 144 147
11. JT Anderson AE Ting S Boozer KR Brunden C Crumrine J Danzig T Dent L Faga JJ Harrington WF Hodnick SM Murphy G Pawlowski R Perry A Raber SE Rundlett A Stricker-Krongrad J Wang YL Bennani 2005 Identification of novel and improved antimitotic agents derived from noscapine J Med Chem 48 7096 7098
12. JT Anderson AE Ting S Boozer KR Brunden J Danzig T Dent JJ Harrington SM Murphy R Perry A Raber SE Rundlett J Wang N Wang YL Bennani 2005 Discovery of S-phase arresting agents derived from noscapine J Med Chem 48 2756 2758
13. R Aneja J Zhou SN Vangapandu B Zhou R Chandra HC Joshi 2006 Drug-resistant T-lymphoid tumors undergo apoptosis selectively in response to an antimicrotubule agent, EM011 Blood 107 2486 2492
14. J Zhou K Gupta S Aggarwal R Aneja R Chandra D Panda HC Joshi 2003 Brominated derivatives of noscapine are potent microtubule-interfering agents that perturb mitosis and inhibit cell proliferation Mol Pharmacol 63 799 807
15. JW Landen R Lang SJ McMahon NM Rusan AM Yvon AW Adams MD Sorcinelli R Campbell P Bonaccorsi JC Ansel DR Archer P Wadsworth CA Armstrong HC Joshi 2002 Noscapine alters microtubule dynamics in living cells and inhibits the progression of melanoma Cancer Res 62 4109 4114
16. J Zhou K Gupta J Yao K Ye D Panda P Giannakakou HC Joshi 2002 Paclitaxel-resistant human ovarian cancer cells undergo c-Jun NH2-terminal kinase-mediated apoptosis in response to noscapine J Biol Chem 277 39777 39785
17. J Zhou M Liu R Luthra J Jones R Aneja R Chandra RR Tekmal HC Joshi 2005 EM012, a microtubule-interfering agent, inhibits the progression of multidrug-resistant human ovarian cancer both in cultured cells and in athymic nude mice Cancer Chemother Pharmacol 55 461 465
18. Y Ke K Ye HE Grossniklaus DR Archer HC Joshi JA Kapp 2000 Noscapine inhibits tumor growth with little toxicity to normal tissues or inhibition of immune responses Cancer Immunol Immunother 49 217 225
19. N Heidari B Goliaei PR Moghaddam N Rahbar-Roshandel M Mahmoudian 2007 Apoptotic pathway induced by noscapine in human myelogenous leukemic cells Anticancer Drugs 18 10 1139 1147
20. JW Landen V Hau M Wang T Davis B Ciliax BH Wainer EG Van Meir JD Glass HC Joshi DR Archer 2004 Noscapine crosses the blood-brain barrier and inhibits glioblastoma growth Clin Cancer Res 10 5187 5201
21. K Ye Y Ke N Keshava J Shanks JA Kapp RR Tekmal J Petros HC Joshi 1998 Opium alkaloid noscapine is an antitumor agent that arrests metaphase and induces apoptosis in dividing cells Proc Natl Acad Sci USA 95 1601 1606
22. MS Shaik A Chatterjee M Singh 2004 Effect of a selective cyclooxygenase (COX)-2 inhibitor, nimesulide on the growth of lung tumors and their expression of COX-2 and peroxisome proliferator-activated receptor-γ Clin Cancer Res 10 1521 1529
23. SV Fulzele A Chatterjee MS Shaik T Jackson N Ichite M Singh 2007 15-Deoxy-Delta12,14-prostaglandin J2 enhances docetaxel antitumor activity against A549 and H460 non-small-cell lung cancer cell lines and xenograft tumors Anticancer Drugs 18 1 65 78
24. MO Karlsson B Dahlstrom SA Eckernas M Johansson AT Alm 1990 Pharmacokinetics of oral noscapine Eur J Clin Pharmacol 39 275 279
25. R Aneja N Dhiman J Idnani A Awasthi SK Arora R Chandra HC Joshi 2007 Preclinical pharmacokinetics and bioavailability of noscapine, a tubulin-binding anticancer agent Cancer Chemother Pharmacol 60 831 839
26. B Dahlstrom T Mellstrand CG Lofdahl M Johansson 1982 Pharmacokinetic properties of noscapine Eur J Clin Pharmacol 22 535 539
27. SH Kaufmann S Desnoyers Y Ottaviano NE Davidson GG Poirier 1993 Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis Cancer Res 53 3976 3985
28. R Aneja AM Ghaleb J Zhou VW Yang HC Joshi 2007 p53 and p21 Determine the sensitivity of noscapine-induced apoptosis in colon cancer cells Cancer Res 67 3862 3870